Restoring SIRT6 levels in VSMCs protects against atherosclerosis, plaque cell senescence, and inflammation and preserves features of plaque stability, revealing a therapeutic potential of SIRT6 in atherosclerosis. The gene discussed is SIRT6; the disease is atherosclerosis.